Renaissance Technologies - TEKMIRA PHARMACEUTICALS CORP ownership

TEKMIRA PHARMACEUTICALS CORP's ticker is TKMR and the CUSIP is 87911B209. A total of 79 filers reported holding TEKMIRA PHARMACEUTICALS CORP in Q1 2015. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TEKMIRA PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2014$408,000
-15.9%
26,700
+16.6%
0.00%0.0%
Q3 2014$485,000
-75.3%
22,900
-84.8%
0.00%
-80.0%
Q2 2014$1,962,000
+261.3%
150,200
+500.8%
0.01%
+400.0%
Q1 2014$543,00025,0000.00%
Other shareholders
TEKMIRA PHARMACEUTICALS CORP shareholders Q1 2015
NameSharesValueWeighting ↓
QVT Financial LP 16,013,540$279,596,00015.57%
RA Capital Management 2,714,800$47,400,0004.71%
Alpha Wave Global, LP 2,221,000$38,779,0001.90%
Redmile Group, LLC 700,000$12,222,0001.10%
HealthCor Management, L.P. 718,800$12,550,0000.60%
Monashee Investment Management LLC 55,000$960,0000.60%
SPHERA FUNDS MANAGEMENT LTD. 298,486$5,212,0000.54%
Telemetry Investments, L.L.C. 48,000$838,0000.46%
Anson Funds Management LP 25,000$437,0000.39%
Blue Ridge Capital, L.L.C. 1,700,000$29,682,0000.34%
View complete list of TEKMIRA PHARMACEUTICALS CORP shareholders